Takayuki Shibata

Dr. Takayuki Shibata

Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
QZQinchang Zhu
Qinchang Zhu
Takayuki ShibataTakayuki Shibata
Takayuki Shibata
TKTsutomu Kabashima
Tsutomu Kabashima
MKMasaaki Kai
Masaaki Kai

1 January 2005 in Nucleic Acids Research
Verified
Journal Article
Open access
JBJohn A. Brazier
John A. Brazier
Takayuki ShibataTakayuki Shibata
Takayuki Shibata
JTJohn Townsley
John Townsley
BTBrian F. Taylor
Brian F. Taylor
EFElaine Frary
Elaine Frary
DWDavid Williams
David Williams
The incorporation of C5-amino-modified 2′-deoxyuridine analogues into DNA have found application in nucleic acid labelling, the stabilization of nucleic acid structures, functionalization of nucleic acid aptamers and catalysts, and the investigation of sequence-specific DNA bending. In this study, we describe the physicochemical properties of four different C5-amino-modified 2′-deoxyuridines in which the amino group is tethered to the base via a 3-carbon alkyl, Z- or E-alkenyl or alkynyl linker. Conformational parameters of the nucleosides and their pKa values were deduced using 1H NMR. All of them display the expected anti-conformation of the nucleoside with 2′-endo sugar puckers for the deoxyribose ring. A preference for the cisoid conformation for the Z-alkenyl analogue is found, while the E-alkenyl analogue exists exclusively as its transoid conformation. The pKa values range from 10.0 for the analogue with an aliphatic propyl linker to 8.5 for the propargylamino analogue. The analogues have been used for the synthesis of triple-helix forming oligonucleotides (TFOs) in which they replace thymidine in the natural sequence. Oligonucleotides containing the propargylamino analogue display the highest stability especially at low pH, while those containing analogues with propyl and especially Z-alkenyl linkers are destabilized to a great extent. TFOs containing the analogue with the E-alkenyl linker have stability similar to the unmodified structures. The chemical synthesis of TFOs containing the analogue, 5-(3-hydroxyprop-1-ynyl)-2′-deoxyuridine that possesses a neutral but polar side chain show a remarkable stability, which is higher than that of all TFOs containing the alkylamino or alkenylamino analogues and only slightly lower than that of TFOs containing the propargylamino analogue. Both the hydroxyl and propargylamino substitutions impart enhanced triple-helix stability relative to the analogous sequences containing C5-propynyl-2′-deoxyuridine. Furthermore, a similar dependence of stability on pH is found between TFOs containing the hydroxypropynyl modifications and those containing the propargylamino side chains. This suggests that the major factor responsible for stabilizing such triple helices is due to the presence of the alkyne with an attached electronegative group.

1 February 2010 in Analytical Biochemistry
Verified
Journal Article
Closed access
ZYZhiqiang Yu
Zhiqiang Yu
TKTsutomu Kabashima
Tsutomu Kabashima
CTChenhong Tang
Chenhong Tang
Takayuki ShibataTakayuki Shibata
Takayuki Shibata
KKKaio Kitazato
Kaio Kitazato
MKMasaaki Kai
Masaaki Kai

1 March 2008 in Peptides
Verified
Journal Article
Closed access
TKTsutomu Kabashima
Tsutomu Kabashima
ZYZhiqiang Yu
Zhiqiang Yu
CTChenhong Tang
Chenhong Tang
YNYoshiki Nakagawa
Yoshiki Nakagawa
KOKyosuke Okumura
Kyosuke Okumura
MKMasaaki Kai
Masaaki Kai

1 January 2006 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Takayuki ShibataTakayuki Shibata
Takayuki Shibata
NGNicola Glynn
Nicola Glynn
TMT. Brian H. McMurry
T. Brian H. McMurry
RMR. Stanley McElhinney
R. Stanley McElhinney
GMGeoffrey P. Margison
Geoffrey P. Margison
DWDavid Williams
David Williams
The human DNA repair protein O6 -methylguanine DNA methyltransferase (MGMT) dealkylates mutagenic O6 -alkylguanine lesions within DNA in an irreversible reaction which results in inactivation of the protein. MGMT also provides resistance of tumours to alkylating agents used in cancer chemotherapy and its inactivation is therefore of particular clinical importance. We describe a post-DNA synthesis strategy which exploits the novel, modified base 2-amino-6-methylsulfonylpurine and allows access for the first time to a wide variety of oligodeoxyribonucleotides (ODNs) containing O6 -alkylguanines. One such ODN containing O6 -(4-bromothenyl)guanine is the most potent inactivator described to date with an IC 50 of 0.1 nM.

13 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SYSheng Yin
Sheng Yin
TKTsutomu Kabashima
Tsutomu Kabashima
QZQinchang Zhu
Qinchang Zhu
Takayuki ShibataTakayuki Shibata
Takayuki Shibata
MKMasaaki Kai
Masaaki Kai
We developed an assay method for measuring dihydroorotate dehydrogenase (DHODH) activity in cultured HeLa cells and fibroblasts, and in stage III stomach cancer and adjacent normal tissues from the same patient. The assay comprised enzymatic reaction of DHODH with a large amount of dihydroorotic acid substrate, followed by fluorescence (FL) detection specific for orotic acid using the 4-trifluoromethyl-benzamidoxime fluorogenic reagent. The DHODH activities in the biologically complex samples were readily measured by the assay method. Our data indicate significantly higher DHODH activity in HeLa cells (340 ± 25.9 pmol/105 cells/h) than in normal fibroblasts (54.1 ± 7.40 pmol/105 cells/h), and in malignant tumour tissue (1.10 ± 0.19 nmol/mg total proteins/h) than in adjacent normal tissue (0.24 ± 0.11 nmol/mg total proteins/h). This is the first report that DHODH activity may be a diagnostic biomarker for cancer.